Latest Regulation News

Cauldron Energy has begun trading on the US OTCQB market, broadening access to American investors without issuing new shares. This move taps into growing US demand for uranium, positioning Cauldron as a potential supplier from its Yanrey Uranium Project.

Sierra Nevada Gold (ASX: SNX) has discovered a new high-grade gold-silver-polymetallic breccia beneath shallow cover at its As Safra project in Saudi Arabia, revealing a more complex and extensive mineral system than previously known.

Maritana Minerals has secured key regulatory approvals and is progressing critical non-process infrastructure at its Black Swan Processing Hub, keeping the project on track for first gold production in the second half of 2027.

Forrestania Resources has extended its off-market takeover offer for Zenith Minerals shares to 31 August 2026, while ASIC has approved a faster payment window that removes withdrawal rights for shareholders.

Wia Gold’s Kokoseb Gold Project in Namibia jumps to 3.78 million ounces in updated resource estimate, unveiling a maiden underground inferred resource and reinforcing its development potential.

BetMakers Technology Group has inked a binding deal for Tabcorp to acquire it at a 45.5% premium, valuing the wagering tech firm at about $283 million. Shareholders can opt for cash or a mix of cash and Tabcorp shares, with completion aimed for Q3 FY27.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

Contact Energy (ASX:CEN) posted a 62% jump in FY26 net profit to NZD 423 million, driven by its Manawa acquisition and a near 98% renewable generation mix, while committing to net zero emissions by 2035.

American Tungsten & Antimony plans to restart and expand the Del Sol Refinery and White Spar Mine in the US, contingent on completing their acquisition. The company is preparing for increased processing capacity and new product lines while engaging with regulators and engineering firms.

AdAlta’s lead CAR-T therapy EW-001 has achieved a rare clinical milestone with one mesothelioma patient remaining cancer-free two years after treatment, and a second reaching one-year survival, underscoring the therapy’s potential durability in a notoriously difficult cancer.

Light & Wonder's Q2 2026 sees net income jump 26% to $120 million, driven by strong Gaming and iGaming growth. The company sticks to its 2026 outlook, targeting mid- to high-single-digit EBITDA growth and aims to reduce leverage below 3.0x by mid-2027.

Future Metals NL has launched an updated Scoping Study for its Panton PGM-Ni-Cr Project, weighing a greenfield standalone operation against leveraging the idle Savannah processing facility to identify a cost-effective development route.